TET2 and heart failure: The presence of common CHIP variants DNMT3 A and TET2 is significantly associated with an increased risk of mortality combined with heart failure hospitalization (HR, 2.1; 95% CI, 1.1–4.0; p = 0.02), independent of traditional cardiovascular risk factors [201, 202].